http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4eb379f857b773ef867a087f7fb29c21
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Aaron D. Schimmer Schimmer |
| name | Aaron D. Schimmer Aaron D Schimmer |
| given-name | Aaron D Aaron D. |
| organization-name | 1Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; 2Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. Princess Margaret Hospital, Ontario Cancer Institute, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre University Health Network Toronto Ontario Canada The Toronto Hospital Oncology Gene Therapy Program Toronto, Ontario, Canada University of Toronto; Ontario Cancer Institute, University Health Network; Princess Margaret Hospital, University Health Network, Toronto, ON, Canada Princess Margaret Cancer Centre University Health Network Toronto Ontario Canada Ontario Cancer Institute, Princess Margaret Hospital, Toronto, ON;; McLaughlin Centre for Molecular Medicine, University of Toronto, Toronto, ON; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada Princess Margaret Cancer Center, Ontario Cancer Institute, Toronto, ON, Canada; Princess Margaret Hospital, Ontario Cancer Institute, Toronto, ON; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. Princess Margaret Cancer Centre University of Toronto Toronto ON Canada Department of Medical Biophysics, Faculty of Medicine, University of Toronto, Toronto, Ontario M5G 1L7, Canada; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 1L7, Canada Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; and 1Ontario Cancer Institute, Princess Margaret Hospital,; 2Department of Medical Biophysics, University of Toronto, Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Ontario, Canada 1Burnham Institute for Medical Research, La Jolla, California;; 2Princess Margaret Hospital, Ontario Cancer Institute;; 3The McLaughlin Centre for Molecular Medicine, Toronto, Ontario, Canada; and Princess Margaret Cancer Centre, University Health Network, 101 College Street, Toronto, ON M5G 1L7, Canada Princess Margaret Hospital, Ontario Cancer Institute, Toronto, ON, Canada Princess Margaret Cancer Centre, Toronto, ON, Canada; Authors' Affiliations: 1Princess Margaret Hospital, Ontario Cancer Institute; 2Department of Chemistry, University of Toronto; 3Department of Molecular Genetics, Donnelly Centre for Cellular and Biomolecular Research, Toronto, Ontario, Canada and 4Burnham Institute for Medical Research, La Jolla, California Division Medical Oncology & Haematology Princess Margaret Cancer Centre Toronto Ontario Canada Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 2M9, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 1L7, Canada Princess Margaret Cancer Centre, University Health Network, Toronto, Canada Authors' Affiliations: 1Department of Biochemistry, Donnelly Centre for Cellular and Biomolecular Research, University of Toronto; 2Centre for Systems Biology, Samuel Lunenfeld Research Institute; 3Princess Margaret Hospital, Ontario Cancer Institute; 4Medicinal Chemistry Platform, Ontario Institute for Cancer Research, Toronto, Ontario; 5BC Cancer Research Centre, Vancouver, British Columbia, Canada; 6Institute for Advancing Medical Innovation, The University of Kansas Cancer Center, Kansas City, Missouri; 7The Leukemia and Lymphoma Society, White Plains, New York; and 8College of Animal Sciences, Zhejiang University, Hangzhou, Zhejiang, China Department of Medical Oncology and Hematology Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada Department of Medical Oncology and Hematology Princess Margaret Cancer Centre University of Toronto Toronto ON Canada *Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Princess Margaret Hospital, Ontario Cancer Institute, Toronto, ON Medical Biophysics, Princess Margaret Hospital / Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada PRINCESS MARGARET HOSPITAL From the University of Texas MD Anderson Cancer Center, Houston, TX; the Ontario Cancer Institute, the Princess Margaret Hospital, the University Health Network, and the McLaughlin Center for Molecular Medicine, Toronto, Ontario, Canada; the Burnham Institute, and the Torrey Pines Institute for Molecular Studies, La Jolla, CA. 1Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Ontario, Canada; 1University of Toronto, Toronto, Ontario, Canada.; 2Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada. 1Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada;; 2Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Ontario, Canada; and Princess Margaret Cancer Centre, Ontario Cancer Institute, Toronto, ON, Canada; Division of Hematology and Oncology, The Princess Margaret Hospital and the Ontario Cancer Institute, 610 University Avenue, Toronto, ON, M5G2M9, Canada Departments of Medicine (X.Z., X.M., R.H., A.D.S., S.E.) Toronto, Ontario, Canada M5G-2M9; University Health Network, The Ontario Cancer Institute (X.Z., X.M., R.H., A.D.S., S.E., S.L.A.) Toronto, Ontario, Canada M5G-2M9 2The Princess Margaret Hospital and the Ontario Cancer Institute, Toronto, Ontario, Canada Departments of Molecular Genetics, Biochemistry, and Chemistry, The University of Toronto, Toronto, Ontario M5S 1A8, Canada, Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Ontario M5G 2M9, Canada, and Molecular Structure and Function, The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada Division of Medical Oncology and Hematology Princess Margaret Hospital University Health Network Toronto ON Canada From the Princess Margaret Hospital, University Health Network, Toronto, ON, Canada. 3Department of Medical Biophysics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; 4Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada 13Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Canada; 4Princess Margaret Cancer Centre, Toronto, Ontario, Canada. Ontario Cancer Institute, Princess Margaret Hospital, 620 University Avenue, Toronto, Ontario, Canada M5G 2C1 Princess Margaret Cancer Centre University Health Network Toronto Canada; Department of Medical Biophysics University of Toronto Toronto Canada 1Princess Margaret Hospital, Ontario Cancer Institute; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Institute of Medical Sciences, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada Princess Margaret Cancer Centre, Toronto, Ontario M5G 1L7, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 1L7, Canada. 1Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; 2Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. 1Princess Margaret Cancer Centre and University Health Network Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 2M9, Canada. Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada M5G 2M9.; Ontario Cancer Institute/Campbell Family Cancer Research Institute, University Health Network, Toronto, Ontario, Canada M5G 2M9. Princess Margaret Cancer Centre, Toronto, Ontario, Canada Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada From the Princess Margaret Hospital, Ontario Cancer Institute, Toronto, Ontario; Maisonneuve-Rosemont Hospital; Aegera Therapeutics Inc, Montreal, Quebec, Canada; M. D. Anderson Cancer Center, Houston, TX; David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Northwestern University Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center, Chicago, IL; and Johns Hopkins University, Baltimore, MD. The Princess Margaret Hospital and The Ontario Cancer Institute, Toronto, ON; and; The Sinai-McLaughlin Assay and Robotic Technologies Facility, Mount Sinai Hospital, Toronto, ON 1Ontario Cancer Institute, Princess Margaret Hospital and Princess Margaret Hospital and the Ontario Cancer Institute, Toronto, ON;; McLaughlin Centre for Molecular Medicine, Toronto, ON;; Department of Medicine, University of Toronto, Toronto, ON;; Department of Medical Biophysics, University of Toronto, Toronto, ON; Princess Margaret Cancer Centre and University of Toronto, Canada The Burnham Institute, La Jolla, California 92037, USA. 1Ontario Cancer Institute, Princess Margaret Hospital,; 4Medical Biophysics,; 6Medicine, University of Toronto, Toronto, ON, Canada Department of Hematology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, ON, Canada; 5The Burnham Institute, La Jolla, California 1Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada 3Princess Margaret Cancer Center, Ontario Cancer Institute, Toronto, Ontario, Canada. The Princess Margaret Hospital, The Ontario Cancer Institute, Toronto, ON; Princess Margaret Hospital and the Ontario Cancer Institute, Toronto, ON; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; |
Incoming Links
Total number of triples: 279.